Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 325

3.

The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women.

Barrett-Connor E, Slone S, Greendale G, Kritz-Silverstein D, Espeland M, Johnson SR, Waclawiw M, Fineberg SE.

Maturitas. 1997 Jul;27(3):261-74.

PMID:
9288699
5.

Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.

Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E.

Ann Intern Med. 1999 Feb 16;130(4 Pt 1):262-9.

PMID:
10068383
6.

Estrogen, progestogens and cardiovascular risk.

Stefanick ML.

J Reprod Med. 1999 Feb;44(2 Suppl):221-6. Review.

PMID:
11392036
7.

Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.

Espeland MA, Hogan PE, Fineberg SE, Howard G, Schrott H, Waclawiw MA, Bush TL.

Diabetes Care. 1998 Oct;21(10):1589-95.

PMID:
9773716
8.
10.

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH; Women's Health Initiative Memory Study.

JAMA. 2004 Jun 23;291(24):2947-58.

PMID:
15213206
12.

Effects of estrogen with and without progestin on urinary incontinence.

Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, Aragaki A, Naughton MJ, Wallace RB, McNeeley SG.

JAMA. 2005 Feb 23;293(8):935-48.

PMID:
15728164
13.

Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial.

Greendale GA, Reboussin BA, Hogan P, Barnabei VM, Shumaker S, Johnson S, Barrett-Connor E.

Obstet Gynecol. 1998 Dec;92(6):982-8.

PMID:
9840563
14.

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate.

Pickar JH, Yeh I, Wheeler JE, Cunnane MF, Speroff L.

Fertil Steril. 2001 Jul;76(1):25-31.

PMID:
11438315
15.

Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.

Vigna GB, DonegĂ  P, Zanca R, Barban A, Passaro A, Pansini F, Bonaccorsi G, Mollica G, Fellin R.

Metabolism. 2002 Nov;51(11):1463-70.

PMID:
12404199
16.

Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.

Christodoulakos GE, Lambrinoudaki IV, Panoulis CP, Papadias CA, Kouskouni EE, Creatsas GC.

Gynecol Endocrinol. 2004 May;18(5):244-57.

PMID:
15346660
17.

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results.

Pickar JH, Yeh IT, Wheeler JE, Cunnane MF, Speroff L.

Fertil Steril. 2003 Nov;80(5):1234-40.

PMID:
14607581
18.

Effects of estrogen and medroxyprogesterone acetate on subpopulations of triglyceride-rich lipoproteins and high-density lipoproteins.

Lamon-Fava S, Posfai B, Asztalos BF, Horvath KV, Dallal GE, Schaefer EJ.

Metabolism. 2003 Oct;52(10):1330-6.

PMID:
14564686
20.

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.

Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, Levy RI, Hulley SB.

JAMA. 2000 Apr 12;283(14):1845-52.

PMID:
10770146
Items per page

Supplemental Content

Write to the Help Desk